The digital healthcare consent platform, Flynotes, has successfully secured funding from NPIF - Maven Equity Finance, managed by Maven Capital Partners and part of the Northern Powerhouse Investment Fund, and the GM&C Life Sciences Fund, managed by Catapult Ventures. 

Flynotes is addressing a major issue faced by doctors, dentists and patients alike: gaining valid and informed consent prior to delivering or receiving dental and medical treatment. Its platform provides a simple and effective digital solution to the current paper-based consent and disclosure process. This innovative interface between patients and health professionals is streamlining consent to treatment, removing inefficiencies brought about by paper forms and providing a fully compliant audit trail.

DefiniGEN, a provider of human cell products and services, has raised £3.25 million to accelerate its next phase of growth. This includes £2 million from BGF, the UK’s most active investor, alongside its existing consortium of investors led by 24Haymarket.

DefiniGEN is a spin-out from the University of Cambridge, creating highly predictive disease cell models for preclinical research and drug development. The process of bringing new drugs to market is arduous, expensive and blighted by a high failure rate. DefiniGEN’s models help the biopharma industry to respond to these challenges, enabling highly relevant information on potential new drug efficacy to be realised in an accelerated manner.

Ingenion Medical Limited has been awarded nearly £100,000 in grant funding from Innovate UK, the country’s innovation agency. Ingenion will use the proceeds over the next six months to gain a CE Mark for its CymActive™ urinary catheter, a novel medical device to treat male patients suffering from chronic urinary retention. 

BiVictriX Therapeutics has completed a £1m funding round from existing shareholders including Acceleris Private Investors, the Development Bank of Wales & BioCity Investments, alongside the Future Fund.

Navenio, the healthcare scale-up whose location-based technology has been shown to double the throughput of hospital teams, has secured a £400,000 grant from the UK government and Innovate UK, the UK’s innovation agency, to address the impact of COVID-19 on hospitals.

Pembroke VCT has made an initial investment of £2 million into Eave, a UK-based tech start-up which has developed a unique hearing protection system for construction workers.

Psyomics Ltd, a UK-based healthtech and University of Cambridge spin-out, has closed a £1.5 million  funding round from existing and new investors to bring its mental health assessment and diagnosis platform, Censeo, to market in the UK. University spinout specialists Parkwalk led the round, joined by fellow existing investors Jonathan Milner, Martlet, and Cambridge Enterprise.

Disease Screening and Diagnosis startup, Occuity has raised more than £1m, supported by Angel Investment Network, the world’s largest online angel investment platform. Occuity is developing products to screen for, diagnose and monitor major chronic health conditions including diabetes and Alzheimer’s Disease. Reading-based Occuity has developed a non-invasive optical device that works by detecting markers that the body deposits in the eye. 

An innovative new system that has the potential to revolutionise hearing tests globally has received financial backing from Scottish business angel investment syndicate, Archangels.  Edinburgh-based Hearing Diagnostics Limited has received £715,000 of investment which will enable its hearing test system to undergo trials with universities and hearing aid retailers in the UK with a view to full market launch in 2021.

The £5m investment, made on behalf of the Baronsmead VCTs, is in addition to further investment from existing shareholders and will support the expansion of eConsult Health into the secondary care market.

Beyond maintaining its position as the leading digital triage services in GP surgeries, eConsult Health will continue the rollout of its Urgent and Emergency Care triage solution, eTriage, and outpatient referral software, eSpecialist.

Ori Biotech Ltd (Ori), a leading innovator in cell and gene therapy (CGT) manufacturing, today announced the successful close of a $30 million Series A financing round, bringing the company’s total funding to date to $41 million. The new funding will be used to help bring Ori’s innovative manufacturing platform to the market. The Ori platform delivers scalable solutions to flexibly address the critical clinical and commercial manufacturing needs of CGT developers.

British digital health start-up Clin-e-cal has raised over £130,000 on leading crowdfunding platform Crowdcube to fund the commercialisation and scale-up of its smart inhaler monitoring technology. Clin-e-cal’s smartphone apps use unique SoundResponse® technology, which analyses sound signals asscociated with the inhaler device. The apps then use these sound signals to provide real-time visual feedback to users on their inhalation technique, as well as tracking their adherence.